Trial Profile
Phase II Trial of Motexafin Gadolinium (MGd) in Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2016
Price :
$35
*
At a glance
- Drugs Motexafin gadolinium (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Sponsors Pharmacyclics
- 01 Sep 2005 New trial record.